Porphyromonas gingivalis virulence factors

Porphyromonas gingivalis virulence factors are a diverse set of molecules produced by the keystone periodontal pathogen P. gingivalis to facilitate its survival, colonization, and pathogenicity. The primary factors include cysteine proteases known as gingipains (RgpA, RgpB, and Kgp), fimbriae (FimA and Mfa1), lipopolysaccharides (LPS), and the enzyme peptidylarginine deiminase (PPAD) [1]. Gingipains are crucial for degrading host proteins to acquire nutrients and for evading the immune system by cleaving complement factors and cytokines [1]. Fimbriae allow the bacteria to adhere to host tissues and form biofilms, while PPAD contributes to protein citrullination, a process linked to the development of rheumatoid arthritis [2]. These factors are also implicated in the pathogenesis of Alzheimer's disease, as gingipains have been identified in the brains of patients and are associated with neurotoxicity and proteinopathy [3]. Therapeutic approaches targeting these factors include small-molecule gingipain inhibitors like atuzaginstat, which aim to block destructive proteolytic activity and reduce the systemic impact of the infection [3]. Sources: [1] How, K. Y., Song, K. P., & Chan, K. G. (2016). Porphyromonas gingivalis: An Overview of Periodontopathic Bacterium—Its Virulence Factors and Strategies for Its Survival and Persistence. Frontiers in Microbiology. [2] Wegner, N., et al. (2010). Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: Implications for autoimmunity in rheumatoid arthritis. Arthritis & Rheumatism. [3] Dominy, S. S., et al. (2019). Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Science Advances.

Other names

P. gingivalis pathogenicity factorsGingipainsFimbriaePorphyromonas gingivalis peptidylarginine deiminase (PPAD)P. gingivalis secretome

Inhibition of gingipain cysteine proteases (Kgp and Rgp), competitive inhibition of bacterial adhesion, and broad-spectrum antimicrobial activity to reduce bacterial load and associated inflammatory signaling.